Major domestic pharmaceutical companies were all shocked when they saw the price of Sanqing anti-cancer drugs entering medical insurance.
Raging anger spewed from the hearts of pharmaceutical company CEOs.
"Is this Wei Kang a fool? How dare he set such a low price?"
"This is going to drive us to death."
"He wants to monopolize the anti-cancer drug market. He is simply too ambitious to be the son of a man!"
"It's so black-hearted. I actually believe that he will cooperate with us to develop the anti-cancer drug market."
Incompetent rage is followed by deep fear.
"It seems that the anti-cancer drug market is about to change."
"The company should transform as soon as possible."
"All generic anti-cancer drugs have been given up. No matter how cheap they are, no one will buy them, let alone expensive self-developed drugs."
"We can only try our best to open up overseas markets. We have to sell anti-cancer drugs abroad."
"Pfizer is currently selling Sanqing anti-cancer drugs in Europa and Eagle Country, but in the vast third world countries, the market there is still blank, and we still have a lot of room for development."
"If you can't afford to offend, you can always hide. Sanqing currently only has one anti-cancer drug, and our company has many types of drugs. We are ready to invest all our resources in other fields and completely abandon the anti-cancer drug market."
"That's it. I don't believe Sanqing can launch other new drugs so quickly."
Pharmaceutical company CEOs are busy communicating with familiar colleagues, and then changing their strategic layout, withdrawing from the anti-cancer drug market, investing all resources in other pharmaceutical fields, and going out to seize overseas markets.
Among them, Xinmei Group suffered the most severe blow. The Akilenza injection they had just developed was attacked by competitors as soon as it was launched. It was like a heavy punch from the sky and was killed in an instant.
Chairman Wu Shiji was sitting in a high-level office on the Bund, looking at the plummeting stock price and almost crying.
The 800 million new drug investment has been wasted like this, without a single bubble being seen. How can we face the questions from shareholders?
I think I entered the anti-cancer drug track with high spirits, invested heavily in the research and development of new domestic drugs, and finally got results. However, I encountered a monster like Sanqing, which not only developed broad-spectrum anti-cancer drugs, but also raised the price to the bone.
This simply puts all domestic anti-cancer drugs at risk. This price simply cannot recover the cost.
Because almost all targeted drugs and immunological drugs are only for patients with a certain type of cancer. If it is a niche cancer, there are not many patients. If it is not sold at a sky-high price, there is no way to get back the money, and you will lose your pants. .
The more cancers that can be treated, the bigger the market for this anti-cancer drug will be. This is why Sanqing’s broad-spectrum anti-cancer drug swept the market as soon as it was released.
Mr. Wu was stunned, having a premonition that he was about to face a storm from the board of directors. He thought about it, suddenly picked up his cell phone and dialed a familiar number.
"Old Sun, long time no see. How are you doing?"
"Haha, Mr. Wu, why do you, a busy man like you, think of calling me? What's wrong?"
Mr. Wu looked a little embarrassed and quickly squeezed out a smile and said: "Old Sun, you see we have known each other for so many years. Before I founded Xinmei, Mr. Wei from Sanqing was still my old leader. We all We are colleagues in the same department. You see, no one can compare to this friendship."
Sun Chengren, who was on the opposite side, quickly interrupted him: "Stop it, stop it! If you have something to say, say it properly. If you have something to say, please say it quickly. Don't talk about it. We don't have much friendship left after so many years. What did you do back then?" I know it well."
Mr. Wu said with a bitter face: "Oh, I didn't kill everyone back then. I always kept some leeway in view of the friendship back then. Otherwise, do you think Sanqing could still survive until now if I were really ruthless? "
Sun Chengren was silent. Perhaps he remembered some old things from the past. After a long while, he sighed and said, "Tell me what you have to say. I'm a little nostalgic now that I'm old."
Mr. Wu was overjoyed and said quickly: "80% of our company's new anti-cancer drugs are losing money. I want to inquire about the direction of Sanqing's research and development of new drugs to see if I can avoid you. After so many years of competition, I won the old Mr. Wei, in the end, he fell into the hands of Mr. Wei. Sure enough, the waves behind the Yangtze River push the waves ahead, and I am convinced."
Sun Chengren pondered for a moment and said: "R&D is not under my control. I can't help you on this point. If there is any news, I will try to inform you as early as possible so that you Xinmei don't have to waste your efforts."
As he was talking, he suddenly couldn't help laughing wildly: "Haha, Mr. Wu from a listed company worth hundreds of billions also wants to find me a relationship and use the back door? It makes me laugh to death. I couldn't even imagine this scene a few years ago. , holy shit, so damn comfortable.”
Mr. Wu's face remained calm and his heart did not beat. He said with a playful smile: "Don't you have a relationship with Mr. Sun? I can't reach Mr. Wei, who is dealing with Academician Qi and the CEO of Pfizer."
Sun Chengren agreed: "Yes, no one can reach Mr. Wei now, and Mr. Wu is about the same level as me."
Mr. Wu's face couldn't help but he continued to build friendship with a smile: "Haha, you are too polite. It is an honor for me to be on the same level as Mr. Sun. It seems that Brother Sun still remembers the friendship with me back then. This Are you free in two days? Let's have a meal together and meet old friends?"
Mr. Wu and Sun Chengren agreed on a time to get together and finally hung up the phone.
The smile on his face quickly disappeared, and his expression turned gloomy.
After a while, he quickly called his assistant.
"Xiao Zhou, prepare information for me and make a plan for entering the Chinese patent medicine market. The sooner the better, I will use it on the board of directors."
He has made up his mind. Judging from the several drugs developed by Sanqing, Weikang is very strong in Western medicine, and its research and development strength is too strong, which makes people desperate. Instead of worrying fearfully about being caught up by the other party, it is better to find another way and wait until the other party doesn't. How to focus on expanding aggressively and seizing the market.
The Chinese patent medicine market is a very good direction. Sanqing currently has no achievements in this field and has not shown any interest. This is very suitable for Xinmei to flex its muscles.
At the same time, in order to recover the investment losses of Aquilenza Injection, he also decided to explore overseas markets as soon as possible.
A two-pronged approach to overseas markets and Chinese patent medicines will surely create a new world.
Thinking of this, Mr. Wu smiled proudly, and the gloom in his heart was swept away.
****
Eagle Country, Pfizer headquarters.
An extremely spacious large conference room was filled with Pfizer's top board of directors.
A giant screen on the wall showed the CEOs of other pharmaceutical giants.
Different from the sad and angry mood of domestic pharmaceutical companies, the atmosphere in the entire conference room was quite relaxed and happy.
"Then, let's decide happily."
"Our Pfizer anti-cancer drugs are highly effective and have no side effects. Such good drugs must be high-end."
"In the future, we will mainly sell to high-net-worth individuals, the world's richest people, and the high-income middle class. They are our favorite high-end customers. They are rich and generous, and they are very willing to pay for medical treatment and medication."
"As for Merck, Roche, and other companies, you can definitely lower your prices, so that you can grab other customers. After all, Keytruda has been sold for so many years, and you have already earned enough."
"Of course, we will also reach an agreement with the doctors' association and ask them to recommend patients to use various targeted drugs first. Only when the patients develop drug resistance will we grandly launch Sanqing anti-cancer drugs, so that everyone's drugs can be used. If you have the opportunity, you can fully tap into the value of a customer.”
"Look, we at Pfizer should be very sincere."
The CEOs and chairman of the board of directors of various giants on the screen nodded one after another, all looking very satisfied.
"Pfizer is indeed very sincere. Selling it at a high price will only benefit us, not any harm. We just need to lower the price and it will not affect profits too much."
"Yes, those patients at the bottom who could not afford medicine before can now get anti-cancer drugs at reduced prices, and we can also maintain sales. It is a win-win situation."
"Yes, we are also doing good deeds and treating those poor patients."
"High-end customers are more pursuing treatment experience. They choose Sanqing. There is nothing we can do. Now we can divide their respective market scopes, which is the best result."
"Okay, now that everyone has reached a consensus, this meeting has ended successfully."
Seeing that no one had any objections, Pfizer CEO ended the meeting with a smile.
He turned around and praised Andre: "Well done, Andre. Thanks to you for getting this anti-cancer drug early, we can monopolize the global high-end market."
"Congratulations. From today on, you have officially become the President of Pfizer's Global Oncology Division. I hope you can maintain friendship with Sanqing and continue to cooperate."
Andre stood up to a round of applause and accepted the appointment.
He was very excited at the moment. After hard work, he finally got a promotion and a salary increase. The fruits of his harvest were extremely sweet.
After the meeting, he quickly contacted Wei Kang and told him some good news.
"Dear Wei, Pfizer has passed the US$2.5 billion milestone payment."
